We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 20th:
Select Interior Concepts, Inc. : This interior building products installer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
Clarus Corporation (CLAR - Free Report) : This outdoor equipment and lifestyle products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.
Dr. Reddy's Laboratories Limited (RDY - Free Report) : This integrated pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Genocea Biosciences, Inc. : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 38.6% over the last 60 days.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 20th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 20th:
Select Interior Concepts, Inc. : This interior building products installer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.5% over the last 60 days.
SELECT INT CONC Price and Consensus
SELECT INT CONC price-consensus-chart | SELECT INT CONC Quote
Select Interior Concepts’ shares gained 12.2% over the last one month against the S&P 500’s rise of 1.7%. The company possesses a Momentum Score of A.
SELECT INT CONC Price
SELECT INT CONC price | SELECT INT CONC Quote
Clarus Corporation (CLAR - Free Report) : This outdoor equipment and lifestyle products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.
Clarus Corporation Price and Consensus
Clarus Corporation price-consensus-chart | Clarus Corporation Quote
Clarus’ shares gained 3.2% over the last one month. The company possesses a Momentum Score of B.
Clarus Corporation Price
Clarus Corporation price | Clarus Corporation Quote
Dr. Reddy's Laboratories Limited (RDY - Free Report) : This integrated pharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Dr. Reddy's Laboratories Ltd Price and Consensus
Dr. Reddy's Laboratories Ltd price-consensus-chart | Dr. Reddy's Laboratories Ltd Quote
Dr. Reddy's shares gained 10.6% over the last one month. The company possesses a Momentum Score of B.
Dr. Reddy's Laboratories Ltd Price
Dr. Reddy's Laboratories Ltd price | Dr. Reddy's Laboratories Ltd Quote
Genocea Biosciences, Inc. : This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 38.6% over the last 60 days.
Genocea Biosciences, Inc. Price and Consensus
Genocea Biosciences, Inc. price-consensus-chart | Genocea Biosciences, Inc. Quote
Genocea Biosciences’ shares gained 43.4% over the last one month. The company possesses a Momentum Score of A.
Genocea Biosciences, Inc. Price
Genocea Biosciences, Inc. price | Genocea Biosciences, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
This Could Be the Fastest Way to Grow Wealth in 2019
Research indicates one sector is poised to deliver a crop of the best-performing stocks you'll find anywhere in the market. Breaking news in this space frequently creates quick double- and triple-digit profit opportunities.
These companies are changing the world – and owning their stocks could transform your portfolio in 2019 and beyond. Recent trades from this sector have generated +98%, +119% and +164% gains in as little as 1 month.
Click here to see these breakthrough stocks now >>